These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26096409)

  • 1. Does the Prescription of Anxiolytic and Hypnotic Drugs Increase Mortality in Older Adults?
    Pinot J; Herr M; Robine JM; Aegerter P; Arvieu JJ; Ankri J
    J Am Geriatr Soc; 2015 Jun; 63(6):1263-5. PubMed ID: 26096409
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population.
    Hausken AM; Skurtveit S; Tverdal A
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):913-8. PubMed ID: 17486666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anxiolytic agents and hypnotic drugs in Bretagne. Pharmaco-epidemiological study].
    Nguyen JM; Allain H; Martinet JP; Beneton C; Reymann JM; Decombe R
    Ann Med Interne (Paris); 1991; 142(3):163-7. PubMed ID: 1677240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In adults, use of anxiolytic or hypnotic drugs was associated with increased risk for mortality.
    Belknap SM
    Ann Intern Med; 2014 Jul; 161(2):JC11. PubMed ID: 25023265
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study.
    Weich S; Pearce HL; Croft P; Singh S; Crome I; Bashford J; Frisher M
    BMJ; 2014 Mar; 348():g1996. PubMed ID: 24647164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey.
    Belleville G
    Can J Psychiatry; 2010 Sep; 55(9):558-67. PubMed ID: 20840803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The elderly, sleep habits and use of psychotropic drugs by the French population].
    Ohayon M; Caulet M; Lemoine P
    Encephale; 1996; 22(5):337-50. PubMed ID: 9035990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in elderly men with low psychosocial coping resources using anxiolytic-hypnotic drugs.
    Merlo J; Ostergren PO; Månsson NO; Hanson BS; Ranstam J; Blennow G; Isacsson SO; Melander A
    Scand J Public Health; 2000 Dec; 28(4):294-7. PubMed ID: 11228117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality associated with anxiolytic and hypnotic drugs-A systematic review and meta-analysis.
    Parsaik AK; Mascarenhas SS; Khosh-Chashm D; Hashmi A; John V; Okusaga O; Singh B
    Aust N Z J Psychiatry; 2016 Jun; 50(6):520-33. PubMed ID: 26590022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic and hypnotic drug misuse in Thailand: findings from a national household survey.
    Assanangkornchai S; Sam-Angsri N; Rerngpongpan S; Edwards JG
    Drug Alcohol Rev; 2010 Jan; 29(1):101-11. PubMed ID: 20078690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Halcion, an innocent hypnotic?].
    van der Kroef C
    Ned Tijdschr Geneeskd; 1979 Jul; 123(27):1160-1. PubMed ID: 37449
    [No Abstract]   [Full Text] [Related]  

  • 12. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.
    Mancini J; Thirion X; Masut A; Saillard C; Pradel V; Romain F; Pastor MJ; Coudert C; Micallef J
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):494-503. PubMed ID: 16700077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years.
    Mesrine S; Gusto G; Clavel-Chapelon F; Boutron-Ruault MC; Fournier A
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1475-1484. PubMed ID: 29971451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescriptions and consumption of hypnotic and anxiolytic drugs in the South University Hospital of Marseille].
    Villani P; Morciano C; Ambrosi P; Brondino-Riquier R; Bertault-Peres P; Penot-Ragon C; Bouvenot G
    Therapie; 2001; 56(1):11-4. PubMed ID: 11322011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytics and sedatives and risk of fractures: effects of half-life.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 Jan; 82(1):34-43. PubMed ID: 18175030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of the use of anxiolytic and hypnotic drugs in France and in the world].
    Pélissolo A; Boyer P; Lépine JP; Bisserbe JC
    Encephale; 1996; 22(3):187-96. PubMed ID: 8767047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic, hypnotic and sedative medication use in Australia.
    Hollingworth SA; Siskind DJ
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):280-8. PubMed ID: 20073039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical reactions to hypnotic agents in adolescents with free-running disorder.
    Echizenya M; Iwaki S; Suda H; Shimizu T
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):428. PubMed ID: 19566781
    [No Abstract]   [Full Text] [Related]  

  • 19. The prescription of hypnotics.
    S Afr Med J; 1979 Jun; 55(27):1099-100. PubMed ID: 39351
    [No Abstract]   [Full Text] [Related]  

  • 20. [A study on differences of suicide risk in substance use disorder patients by types of an abused substance: a comparison among alcohol, amphetamine, and sedative, hypnotic or anxiolytic use disorder patients].
    Matsumoto T; Matsushita S; Okudaira K; Naruse N; Cho T; Muto T; Ashizawa T; Konuma K; Morita N; Ino A
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Dec; 45(6):530-42. PubMed ID: 21387609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.